Lan Sun

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Positive Breast Cancer

Polycyclic Aromatic Hydrocarbons

Anti Inflammatory

Pulmonary Arterial Hypertension

Top Venues

International journal of molecular sciences

Science advances

Basic research in cardiology

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yihan Zhang, Xing Li, Shang Li, Yu Zhou, Tiantai Zhang, Lan Sun
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management. International journal of molecular sciences 25 (15) (2024)
Yihan Zhang, Xing Li, Shang Li, Yu Zhou, Tiantai Zhang, Lan Sun
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management. International journal of molecular sciences 25 (15) (2024)
Tingting Lv, Zirui Zhang, Haoying Yu, Shuyue Ren, Jingrong Wang, Shang Li, Lan Sun
Tamoxifen Exerts Anticancer Effects on Pituitary Adenoma Progression via Inducing Cell Apoptosis and Inhibiting Cell Migration. International journal of molecular sciences 23 (5) (2022)
Chengjuan Chen, Yuan Yin, Gaona Shi, Yu Zhou, Shuai Shao, Yazi Wei, Lei Wu, Dayong Zhang, Lan Sun, Tian-Tai Zhang
A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine-related JAK-STAT signal. Science advances 8 (33) (2022)
Yongyi Bai, Jingrong Wang, Ying Chen, Tingting Lv, Xiaojian Wang, Chunlei Liu, Hao Xue, Kunlun He, Lan Sun
The miR-182/Myadm axis regulates hypoxia-induced pulmonary hypertension by balancing the BMP- and TGF-β-signalling pathways in an SMC/EC-crosstalk-associated manner. Basic research in cardiology 116 (1) (2021)
Shuyue Ren, Lingtai Jiao, Shiying Yang, Li Zhang, Junke Song, Haoying Yu, Jingrong Wang, Tingting Lv, Lan Sun, Yang Lu, Guanhua Du
A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats. Pharmaceutics 12 (10) (2020)
Haoying Yu, Shuyue Ren, Jingrong Wang, Tingting Lv, Lan Sun, Guanhua Du
Bexarotene combined with lapatinib for the treatment of Cushing's disease: evidence based on drug repositioning and experimental confirmation. Signal transduction and targeted therapy 5 (1) (2020)